AdvisorShares Investments LLC Purchases New Holdings in Aurora Cannabis Inc. $ACB

AdvisorShares Investments LLC purchased a new stake in shares of Aurora Cannabis Inc. (NASDAQ:ACB) in the second quarter, Holdings Channel reports. The firm purchased 50,380 shares of the company’s stock, valued at approximately $214,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Goldman Sachs Group Inc. increased its position in shares of Aurora Cannabis by 4.1% during the first quarter. Goldman Sachs Group Inc. now owns 743,903 shares of the company’s stock valued at $3,266,000 after acquiring an additional 29,099 shares during the last quarter. Cubist Systematic Strategies LLC increased its position in shares of Aurora Cannabis by 358.6% during the first quarter. Cubist Systematic Strategies LLC now owns 238,460 shares of the company’s stock valued at $1,047,000 after acquiring an additional 186,462 shares during the last quarter. Northwest & Ethical Investments L.P. purchased a new stake in shares of Aurora Cannabis during the first quarter valued at approximately $452,000. TD Asset Management Inc increased its position in shares of Aurora Cannabis by 14.0% during the second quarter. TD Asset Management Inc now owns 69,463 shares of the company’s stock valued at $293,000 after acquiring an additional 8,514 shares during the last quarter. Finally, Jones Financial Companies Lllp increased its position in shares of Aurora Cannabis by 9,615.6% during the first quarter. Jones Financial Companies Lllp now owns 52,270 shares of the company’s stock valued at $229,000 after acquiring an additional 51,732 shares during the last quarter. 47.63% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ACB has been the subject of a number of research analyst reports. Zacks Research raised Aurora Cannabis from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Weiss Ratings restated a “sell (d-)” rating on shares of Aurora Cannabis in a research note on Wednesday, October 8th. Finally, Wall Street Zen lowered Aurora Cannabis from a “hold” rating to a “sell” rating in a research note on Friday, July 18th. Two analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Aurora Cannabis presently has a consensus rating of “Moderate Buy”.

Aurora Cannabis Stock Performance

Shares of ACB opened at $4.81 on Friday. The firm has a market cap of $270.43 million, a PE ratio of -25.32 and a beta of 1.75. The stock’s fifty day moving average price is $5.27 and its two-hundred day moving average price is $4.99. The company has a debt-to-equity ratio of 0.06, a current ratio of 2.97 and a quick ratio of 1.51. Aurora Cannabis Inc. has a 1 year low of $3.42 and a 1 year high of $6.91.

Aurora Cannabis (NASDAQ:ACB) last issued its earnings results on Wednesday, August 6th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.37). The firm had revenue of $71.98 million during the quarter, compared to the consensus estimate of $96.83 million. Aurora Cannabis had a negative net margin of 5.66% and a negative return on equity of 1.49%. On average, equities research analysts forecast that Aurora Cannabis Inc. will post 0.46 EPS for the current year.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.